InvestorsHub Logo
Followers 24
Posts 2408
Boards Moderated 0
Alias Born 04/12/2006

Re: Fullpower7 post# 11297

Thursday, 07/30/2020 10:00:44 PM

Thursday, July 30, 2020 10:00:44 PM

Post# of 15819
As institutional investors read this PR over the next week or so they will likely consider investing in OPK. This may take time but Opko now checks all of the boxes
*Over $5 (no longer a penny stock)
*Profitable (. $0.05 last Q)
*Lots of potential growth with
*Rayadine
*Growth hormone
*4kscore cancer test (now approved) and being recognized/recommended by more and more doctors

*But most of all the growth in the testing Lab and all the new contracts being signed. Great exposure now during the Covid, plus for the future after Covid is no longer so dominant in the testing.

We may pick up a few more analysts that will likely come in with a buy or strong buy rating.
Is there any down side (besides the negativity of the shorts)
$10 by end of year should be a sure thing.
DeGen
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News